Table 4 Disease-related variables and variables characteristics of the population studied associated with the expression levels of miR-425-5p and miR-451 stratified by sex.
DCt-425 | DCt-425 | |||||
|---|---|---|---|---|---|---|
r | β | p | r | β | p | |
Men | ||||||
Disease duration | 0.092 | 0.006 | 0.434 | 0.06 | 0.004 | 0.609 |
HAQ | − 0.022 | − 0.031 | 0.853 | − 0.001 | − 0.001 | 0.993 |
DAS28 | − 0.134 | − 0.06 | 0.255 | 0.284 | 0.120 | 0.014 |
ESR | − 0.244 | − 0.005 | 0.036 | 0.385 | 0.008 | 0.001 |
CRP | − 0.156 | − 0.085 | 0.185 | 0.148 | 0.077 | 0.208 |
Fibrinogen | − 0.150 | − 0.001 | 0.203 | 0.435 | 0.002 | 0.0001 |
Age | − 0.56 | − 0.002 | 0.635 | 0.0076 | 0.003 | 0.52 |
BMI | 0.002 | 0.0001 | 0.984 | 0.194 | 0.02 | 0.097 |
SBP | 0.076 | 0.002 | 0.521 | 0.146 | 0.003 | 0.216 |
DBP | 0.028 | 0.001 | 0.810 | 0.069 | 0.003 | 0.558 |
Glucose | 0.024 | 0.001 | 0.840 | 0.016 | 0.0001 | 0.891 |
HbA1c (%) | − 0.081 | − 0.064 | 0.497 | − 0.01 | − 0.008 | 0.932 |
Women | ||||||
Disease duration | 0.091 | 0.004 | 0.29 | 0.036 | 0.001 | 0.680 |
HAQ | 0.109 | 0.086 | 0.203 | 0.127 | 0.096 | 0.138 |
DAS28 | 0.107 | 0.035 | 0.215 | 0.163 | 0.051 | 0.056 |
ESR | − 0.091 | − 0.001 | 0.290 | 0.161 | 0.002 | 0.06 |
CRP | − 0.038 | − 0.02 | 0.662 | 0.147 | 0.075 | 0.087 |
Fibrinogen | − 0.041 | 0.0001 | 0.630 | 0.175 | 0.001 | 0.041 |
Age | − 0.045 | − 0.002 | 0.602 | 0.049 | 0.002 | 0.566 |
BMI | 0.008 | 0.001 | 0.922 | 0.04 | 0.002 | 0.643 |
SBP | − 0.118 | − 0.002 | 0.168 | − 0.043 | − 0.001 | 0.613 |
DBP | − 0.056 | − 0.002 | 0.514 | 0.668 | 0.002 | 0.431 |
Glucose | 0.082 | 0.001 | 0.328 | 0.084 | 0.001 | 0.331 |
HbA1c (%) | 0.059 | 0.027 | 0.493 | 0.089 | 0.038 | 0.303 |